Glucosylceramide modulates endolysosomal pH in Gaucher disease (Q39158612)

9 September 2017

Glucosylceramide modulates endolysosomal pH in Gaucher disease (English)

1 reference

9 September 2017

1 reference

Dan J Sillence

1

1 reference

9 September 2017

3 April 2013

1 reference

Molecular Genetics and Metabolism

9 September 2017

1 reference

9 September 2017

109

1 reference

9 September 2017

194-200

1 reference

9 September 2017

2

1 reference

A vital role for glycosphingolipid synthesis during development and differentiation

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Broad screening test for sphingolipid-storage diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Clathrin-dependent and -independent internalization of plasma membrane sphingolipids initiates two Golgi targeting pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Glucosylceramide modulates membrane traffic along the endocytic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

ARF1 regulates pH-dependent COP functions in the early endocytic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Hyperacidification of trans-Golgi network and endo/lysosomes in melanocytes by glucosylceramide-dependent V-ATPase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Elevated lysosomal pH in Mucolipidosis type IV cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Fluorescence lifetime characterization of novel low-pH probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

A novel acidotropic pH indicator and its potential application in labeling acidic organelles of live cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Secondary sphingolipid accumulation in a macrophage model of Gaucher disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Sphingolipid storage induces accumulation of intracellular cholesterol by stimulating SREBP-1 cleavage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Differential targeting of glucosylceramide and galactosylceramide analogues after synthesis but not during transcytosis in Madin-Darby canine kidney cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Segregation of glucosylceramide and sphingomyelin occurs in the apical to basolateral transcytotic route in HepG2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Modulation in the activity of purified tonoplast H+-ATPase by tonoplast glycolipids prepared from cultured rice (Oryza sativa L. var. Boro) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Modulation of proton pumping across proteoliposome membranes reconstituted with tonoplast H(+)-ATPase from cultured rice (Oryza sativa L. var. Boro) cells by acyl steryl glucoside and steryl glucoside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Molecular probes for sensing the cholesterol composition of subcellular organelle membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

A mouse B16 melanoma mutant deficient in glycolipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Caveolin targeting to late endosome/lysosomal membranes is induced by perturbations of lysosomal pH and cholesterol content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

pH-independent retrograde targeting of glycolipids to the Golgi complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

[14C]Methylamine accumulation in cultured human skin fibroblasts--a biochemical test for lysosomal storage and lysosomal diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Occurrence of an anomalous endocytic compartment in fibroblasts from Sandhoff disease patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Membrane traffic and turnover in TRP-ML1-deficient cells: a revised model for mucolipidosis type IV pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Regulation of the V-ATPase along the endocytic pathway occurs through reversible subunit association and membrane localization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Glucosylceramide accumulation is not confined to the lysosome in fibroblasts from patients with Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Accumulation of Glucosylceramide in Murine Testis, Caused by Inhibition of β-Glucosidase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Sphingolipid Requirement for Generation of a Functional V1 Component of the Vacuolar ATPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Mucolipin-3 regulates luminal calcium, acidification, and membrane fusion in the endosomal pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2013.03.015

10.1016/J.YMGME.2013.03.015

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference

PubMed ID

23628459